Video

Expert discusses studies of Optilume drug-coated balloon for urethral strictures

“What our studies were looking at was a novel device that could potentially help bridge the gap between [endoscopic treatment and urethroplasty] to achieve endoscopic treatment and achieve greater success,” says Justin Chee, MD.

Video Player is loading.
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected

      In this video, Justin Chee, MD, discusses the background and findings of 2 studies he presented at the 2021 International Continence Society Meeting: “The Optilume urethral drug coated balloon for recurrent anterior urethral strictures: 3-year results from the ROBUST I Study,” and “A randomized controlled trial evaluating the Optilume urethral drug coated balloon vs endoscopic management for treatment of recurrent anterior urethral strictures.” Chee is a reconstructive urological surgeon at Murac Health, East Melbourne, Australia.

      © 2025 MJH Life Sciences

      All rights reserved.